{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:39:53Z","timestamp":1792161593885,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish Ministry of Science and Higher Education","award":["N N204 186039"],"award-info":[{"award-number":["N N204 186039"]}]}],"content-domain":{"domain":["nucmedbio.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.nucmedbio.2014.08.012","type":"journal-article","created":{"date-parts":[[2014,8,23]],"date-time":"2014-08-23T02:32:01Z","timestamp":1408761121000},"page":"28-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Synthesis and in vitro\/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals"],"prefix":"10.1016","volume":"42","author":[{"given":"Przemys\u0142aw","family":"Ko\u017ami\u0144ski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Gniazdowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0005","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2004.02160.x","article-title":"Ghrelin: more than a natural GH secretagogue and\/or an orexigenic factor","volume":"62","author":"Ghigo","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yfrne.2004.03.002","article-title":"Ghrelin\u2014a hormone with multiple functions","volume":"25","author":"Korbonits","year":"2004","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0020","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1530\/eje.0.1500173","article-title":"Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines","volume":"150","author":"Cassoni","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0083-6729(06)77004-2","article-title":"The growth hormone secretagogue receptor","volume":"77","author":"Young-Cruz","year":"2007","journal-title":"Vitam Horm"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0030","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/jc.2003-031375","article-title":"Expression of ghrelin and its functional receptor, the type 1a growth hormone secretagogue receptor, in normal human testis and testicular tumors","volume":"89","author":"Gaytan","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0035","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jcem.87.6.8739","article-title":"The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans","volume":"87","author":"Gnanapavan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0040","first-page":"1738","article-title":"Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines","volume":"86","author":"Cassoni","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0045","first-page":"881","article-title":"The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors","volume":"86","author":"Korbonits","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0050","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jcem.86.9.7866","article-title":"GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils","volume":"86","author":"Hattori","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0055","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.regpep.2010.03.011","article-title":"Ghrelin: a potential therapeutic target for cancer","volume":"163","author":"Nikolopoulos","year":"2010","journal-title":"Regul Pept"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0060","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1021\/jm8014519","article-title":"Fluorine and rhenium substituted ghrelin analogues as potential imaging probes for the growth hormone secretagogue receptor","volume":"52","author":"Rosita","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0065","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jm0001727","article-title":"Structure\u2013function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a","volume":"43","author":"Bednarek","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0070","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/bbrc.2001.5553","article-title":"Structure\u2013activity relationship of ghrelin: pharmacological study of ghrelin peptides","volume":"287","author":"Matsumoto","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0075","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/psc.1177","article-title":"Ghrelin\u2014a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues","volume":"15","author":"Chollet","year":"2009","journal-title":"J Pept Sci"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0080","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1210\/en.2006-1281","article-title":"Ghrelin interacts with human plasma lipoproteins","volume":"148","author":"De Vriese","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0085","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.peptides.2004.03.010","article-title":"Ala-scan of ghrelin (1\u201314): interaction with the recombinant human ghrelin receptor","volume":"25","author":"Van Craenenbroeck","year":"2004","journal-title":"Peptides"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0090","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1210\/er.2002-0029","article-title":"Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin","volume":"25","author":"Van Der Lely","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0095","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/sj.bjp.0704228","article-title":"[125I-His9]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue; up-regulation of receptors with atherosclerosis","volume":"134","author":"Katugampola","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0100","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1016\/j.bbamem.2010.07.002","article-title":"Acylated and unacylated ghrelin binding to membranes and to ghrelin receptor: towards a better understanding of the underlying mechanisms","volume":"1798","author":"Staes","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0105","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1021\/cr980435t","article-title":"Potential technetium small molecule radiopharmaceuticals","volume":"99","author":"Jurrisson","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0110","author":"World Nuclear Association"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0115","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1021\/cr9804386","article-title":"Therapeutic radiopharmaceuticals","volume":"99","author":"Volkert","year":"1999","journal-title":"Chem Rev"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.apradiso.2009.07.016","article-title":"\u20182+1\u2019 Tricarbonyltechnetium(I) and -rhenium(I) mixed-ligand complexes with N-methylpyridine-2-carboxyamide and isocyanide or imidazole ligands\u2014potential precursors of radiopharmaceuticals","volume":"68","author":"Fuks","year":"2010","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.apradiso.2010.11.005","article-title":"\u20182+1\u2019 Tricarbonyltechnetium (I)\/tricarbonylrhenium(I) mixed-ligand complexes with methyl thiosalicylate and isocyanide ligands as potential precursors of radiopharmaceuticals","volume":"69","author":"Ko\u017aminski","year":"2011","journal-title":"Appl Radiat Isot"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0130","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10967-013-2526-7","article-title":"Synthesis, radiochemistry and stability of the conjugates of technetium-99m complexes with substance P","volume":"298","author":"Gniazdowska","year":"2013","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0135","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.poly.2007.12.031","article-title":"Structural features of tricarbonyl(N-methyl-2-pyridinecarboxyamide)chloro-rhenium(I)\u2014potential precursor of radiopharmaceuticals","volume":"27","author":"Fuks","year":"2008","journal-title":"Polyhedron"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0020-1693(95)04571-6","article-title":"Synthesis and reactions of trigonal-bipyramidal rhenium and technetium complexes with a tripodal, tetradentate NS3 ligand","volume":"240","author":"Spies","year":"1995","journal-title":"Inorg Chim Acta"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0145","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1021\/bc700197m","article-title":"Organometallic 99mTc(III) \u20184+1' bombesin(7\u201314) conjugates: synthesis, radiolabeling, and in vitro\/in vivo studies","volume":"18","author":"Kunstler","year":"2007","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-328X(94)05373-J","article-title":"Metal carbonyl syntheses XXII. Low pressure carbonylation of [MOCl4]\u2212 and [MO4]\u2212: the technetium(I) and rhenium(I) complexes [NEt4]2[MCl3(CO)3]","volume":"493","author":"Alberto","year":"1995","journal-title":"J Organomet Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0155","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/bc0300798","article-title":"Novel procedures for preparing 99mTc(III) complexes with tetradentate\/monodentate coordination of varying lipophilicity and adaptation to 188Re analogues","volume":"15","author":"Seifert","year":"2004","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0160","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1039\/B400220B","article-title":"A new [2+1] mixed ligand concept based on [99(m)Tc(OH2)3(CO)3]+: a basic study","author":"Mundwiler","year":"2004","journal-title":"Dalton Trans"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0165","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.poly.2009.08.030","article-title":"Tricarbonylrhenium(I) complexes with anionic ligands containing S and O donor atoms\u2014potential radiopharmaceutical precursors","volume":"29","author":"Fuks","year":"2010","journal-title":"Polyhedron"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/bc049745a","article-title":"Mixed-ligand rhenium-188 complexes with tetradentate\/monodentate NS3\/P (\u20184+1\u2019) coordination: relation of structure with antioxidation stability","volume":"16","author":"Schiller","year":"2005","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0175","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10967-011-1384-4","article-title":"Labelling of peptides with 99mTc complexes through the modified C-terminal group","volume":"292","author":"Ko\u017ami\u0144ski","year":"2012","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0180","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1021\/jf00040a031","article-title":"Formation of pyrazines from the maillard reaction of glucose and lysine-\u03b1-amine-15N","volume":"42","author":"Hwang","year":"1994","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0185","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1210\/en.2004-0569","article-title":"Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites","volume":"145","author":"De Vriese","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0190","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1021\/bc0603788","article-title":"In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7\u201314) analogues containing different amino acid linker moieties","volume":"18","author":"Parry","year":"2007","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2014.08.012_bb0195","first-page":"2409","article-title":"Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors","volume":"19","author":"Garcia-Garayoa","year":"2008","journal-title":"Bioconjug Chem"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114004879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114004879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T06:31:37Z","timestamp":1538289097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805114004879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0969805114004879"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.08.012","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and in vitro\/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}